Ranbaxy
Ranbaxy taken to task by FDA over manufacturing woes
January 31, 2012Manufacturing and Production FDA, Ranbaxy, manufacturing, woes
Indian pharma company Ranbaxy will be banned from manufacturing drugs at certain plants for the US market until it corrects …
Teva gains tentative approval to sell generic Lipitor in 2012
December 5, 2011Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
Teva has gained a tentative approval by the FDA to sell its generic form of Pfizer’s blockbuster statin Lipitor next …
FDA approves Ranbaxy’s generic Lipitor
December 1, 2011Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
The FDA will allow Ranbaxy to develop a generic version of Pfizer’s blockbuster statin Lipitor. The firm has received final …
The changing of the guard – Q3 round up
November 25, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy
PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …
Ranbaxy to collaborate with Teva on generic Lipitor in US?
November 7, 2011Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …
AZ’s Nexium faces generic competition in the UK
September 6, 2011Nexium, Ranbaxy, generics
Generic specialist Ranbaxy has launched its version of AstraZeneca’s anti-ulcer blockbuster Nexium in the UK. It will be available in …
Ranbaxy closes down troubled liquid formulations plant
August 12, 2011Manufacturing and Production FDA, Ranbaxy, pharma manufacturing news, quality control
Indian drugmaker Ranbaxy Laboratories has decided to close down a manufacturing facility in the USA which has been under scrutiny …
Pharma manufacturing news in brief
September 7, 2010Manufacturing and Production Aegis Protek, Alexion, Halozyme, Ranbaxy, SemBioSys
A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …
Ranbaxy chief executive steps down
August 13, 2010Medical Communications, Sales and Marketing Daiichi Sankyo, Ranbaxy
The chief executive of Ranbaxy Mr Atul Sobti is to step down after an apparent a rift with the company’s …
Pharma manufacturing news in brief
May 24, 2010Manufacturing and Production Angel Biotech, Halozyme, Johnson Matthey, Ranbaxy, Sagent Pharmaceuticals, baxter
There are more quality problems to report on the manufacturing beat this week, with recalls for Ranbaxy, Halozyme/Baxter and Sagent …
Ranbaxy woes revealed in FDA warning letter
February 9, 2010Manufacturing and Production Ranbaxy
Ranbaxy has not taken adequate measures to correct deficiencies at its manufacturing plants, according to a communication from the US …
Ranbaxy scales back manufacturing presence in China
January 7, 2010Manufacturing and Production China, Guangzhou Baiyunshan Pharmaceutical Company, HNG Chembio Pharmacy, Hong Kong New Chemic, Ranbaxy
Ranbaxy has shaken up its operations in China with the divestment of its stake a joint venture with Guangzhou Baiyunshan …
Pharma manufacturing news in brief
January 7, 2010Manufacturing and Production Acino, AlphaRx, DSM BioSolutions, Enzon, Indoco Remedies, Jubilant Organosys, Mayoly Spindler, NYK Logistics, Ranbaxy, Venturepharm Laboratories
Our round-up of developments in manufacturing includes contracts for DSM and Venturepharm, facility updates from Indoco and Jubilant, and an …
Ranbaxy woes continue with antibiotic recall
May 6, 2009Sales and Marketing Ranbaxy, US
Indian drugmaker Ranbaxy Laboratories has recalled an antibiotic on sale in the US, suggesting that it still has some way …
FDA puts block on Ranbaxy products
March 4, 2009Manufacturing and Production Ranbaxy
India’s Ranbaxy Laboratories has been dealt another blow by the FDA after the agency suspended regulatory review of any products …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
